Physician Assistant Program year 2025 Reported 2023–2025 Source: CMS Open Payments, 2026 publication

Caroline Jackson

Physician Assistant London, KY Physician Assistant

NPI 1346905742 CMS profile 11264683

272 London Mountain View Dr, London, KY 40741

Open in the dashboard

General payments

$283

15 records reported · program years 2023–2025

Research payments

$0

Paid to them · None reported · program years 2023–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Caroline Jackson of London, KY is reported in the CMS Open Payments database as having received $283 across 15 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 45th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $119 5
2024 General $81 5
2023 General $83 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Caroline Jackson
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Caroline Jackson were reported at $119. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Caroline Jackson Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $0 $132 $37–$438 $132
2022 $0 $155 $48–$522 $149
2023 $83 $167 $52–$557 $160
2024 $81 $178 $55–$600 $164
2025 $119 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2023–2025
  1. Lilly USA, LLC $146 7 payments
  2. Pfizer Inc. $47 3 payments
  3. Novo Nordisk Inc $37 2 payments
  4. Otsuka America Pharmaceutical, Inc. $22 1 payment
  5. ITI, Inc. $16 1 payment
  6. Astellas Pharma US Inc $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2023–2025
  1. Food and Beverage $238 14 payments
  2. Education $45 1 payment
Products named General payments · program years 2023–2025
  1. MOUNJARO $101 6 payments
  2. ELIQUIS $47 3 payments
  3. NURTEC ODT $47 3 payments
  4. RYBELSUS $37 2 payments
  5. Ozempic $37 2 payments
  6. ZEPBOUND $36 2 payments
  7. PAXLOVID $32 2 payments
  8. REXULTI $22 1 payment
  9. TRULICITY $16 1 payment
  10. CAPLYTA $16 1 payment
  11. Other $15 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 74 drugs

Part D claims

2,054

Median for Physician Assistant: 241

Drug cost

$143,195

Median for Physician Assistant: $4,110

Branded share of claims

21.8%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Januvia Sitagliptin Phosphate Brand 15 $24,306
Trulicity Dulaglutide Brand 23 $22,688
Ozempic Semaglutide Brand 20 $22,216
Jardiance Empagliflozin Brand 14 $20,066
Eliquis Apixaban Brand 16 $16,858
Farxiga Dapagliflozin Propanediol Brand 11 $11,892
Humalog Mix 75-25 Insulin Lispro Protamin/Lispro Brand 12 $3,524
Lantus Solostar Insulin Glargine,hum.Rec.Anlog Brand 22 $2,730
Synthroid Levothyroxine Sodium Brand 32 $1,546
Fluticasone Propionate Generic 62 $1,052

The 10 drugs with the highest cost, of 74 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 12 billing codes

Paid by Medicare

$1,575

Medicare's payments for the services billed

Medicare patients

58

Average age 73

Services billed

97

34 women, 24 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 53%
Diabetes 41%
Depression 29%
Cancer 28%
Ischemic heart disease 26%
COPD 26%
Chronic kidney disease 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 6 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
MOUNJARO
  • Lilly USA, LLC $31
$31 — —
Veozah
  • Astellas Pharma US Inc $15
$15 — —
RYBELSUS
  • Novo Nordisk Inc $9
$9 — —
Ozempic
  • Novo Nordisk Inc $9
$9 20 —
ELIQUIS
  • PFIZER INC. $8
$8 16 —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 6 in the dashboard with a free account

Records

15 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Kentucky

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record